African malaria vaccine researcher discusses late-stage clinical trial
With the Day of the African Child drawing attention to the lives of children across the continent, a leading African malaria vaccine researcher discusses progress in the clinical testing of the PATH Malaria Vaccine Initiative's leading vaccine candidate—GlaxoSmithKline Biologicals’ RTS,S. Read more »
Partnering with us
We are pursuing a range of vaccine development approaches with an expanding circle of industry, academic, and government partners.
Our portfolio
We maintain a diverse portfolio of projects, including preclinical feasibility studies, translational projects, and one advanced clinical project.
What we do and how we do it
We provide funding and technical support to partners worldwide to accelerate the development of malaria vaccines. We also work to ensure that malaria vaccines will reach those who need them.
Photo:
Darby Communications/John-Michael Maas
